These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 33442579)

  • 21. Towards a European strategy for medicines research (2014-2020): The EUFEPS position paper on Horizon 2020.
    Gaspar R; Aksu B; Cuine A; Danhof M; Takac MJ; Linden HH; Link A; Muchitsch EM; Wilson CG; Ohrngren P; Dencker L
    Eur J Pharm Sci; 2012 Dec; 47(5):979-87. PubMed ID: 23046836
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coalition Against Major Diseases: Precompetitive Collaborations and Regulatory Paths to Accelerating Drug Development for Neurodegenerative Diseases.
    Stephenson D; Aviles E; Bain LJ; Brumfield M; Carrillo M; Comery TA; Compton C; Corrigan B; Gordon MF; Jack CR; Katz R; Logovinsky V; Satlin A; Marek K; Nicholas T; Polhamus D; Angersbach BS; Raghavan N; Romano G; Romero K; Shaw L; Woodcock J; Vradenburg G; Isaac M
    Ther Innov Regul Sci; 2013 Nov; 47(6):632-638. PubMed ID: 30235546
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Leveraging the regulatory framework to facilitate drug development in Parkinson's disease.
    Müller MLTM; Stephenson DT
    Handb Clin Neurol; 2023; 193():347-360. PubMed ID: 36803822
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Approval of Cancer Drugs With Uncertain Therapeutic Value: A Comparison of Regulatory Decisions in Europe and the United States.
    Salcher-Konrad M; Naci H; Davis C
    Milbank Q; 2020 Dec; 98(4):1219-1256. PubMed ID: 33021339
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Digital phenotyping in Parkinson's disease: Empowering neurologists for measurement-based care.
    Bhidayasiri R; Mari Z
    Parkinsonism Relat Disord; 2020 Nov; 80():35-40. PubMed ID: 32937225
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Toward a Regulatory Qualification of Real-World Mobility Performance Biomarkers in Parkinson's Patients Using Digital Mobility Outcomes.
    Viceconti M; Hernandez Penna S; Dartee W; Mazzà C; Caulfield B; Becker C; Maetzler W; Garcia-Aymerich J; Davico G; Rochester L
    Sensors (Basel); 2020 Oct; 20(20):. PubMed ID: 33092143
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Paediatric Strategy Forum for medicinal product development of chimeric antigen receptor T-cells in children and adolescents with cancer: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration.
    Pearson AD; Rossig C; Mackall C; Shah NN; Baruchel A; Reaman G; Ricafort R; Heenen D; Bassan A; Berntgen M; Bird N; Bleickardt E; Bouchkouj N; Bross P; Brownstein C; Cohen SB; de Rojas T; Ehrlich L; Fox E; Gottschalk S; Hanssens L; Hawkins DS; Horak ID; Taylor DH; Johnson C; Karres D; Ligas F; Ludwinski D; Mamonkin M; Marshall L; Masouleh BK; Matloub Y; Maude S; McDonough J; Minard-Colin V; Norga K; Nysom K; Pappo A; Pearce L; Pieters R; Pule M; Quintás-Cardama A; Richardson N; Schüßler-Lenz M; Scobie N; Sersch MA; Smith MA; Sterba J; Tasian SK; Weigel B; Weiner SL; Zwaan CM; Lesa G; Vassal G
    Eur J Cancer; 2022 Jan; 160():112-133. PubMed ID: 34840026
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Critical Role of Academic Clinical Trials in Pediatric Cancer Drug Approvals: Design, Conduct, and Fit for Purpose Data for Positive Regulatory Decisions.
    De Wilde B; Barry E; Fox E; Karres D; Kieran M; Manlay J; Ludwinski D; Reaman G; Kearns P
    J Clin Oncol; 2022 Oct; 40(29):3456. PubMed ID: 35947814
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Using Digital Tools to Advance Alzheimer's Drug Trials During a Pandemic: The EU/US CTAD Task Force.
    Kaye J; Aisen P; Amariglio R; Au R; Ballard C; Carrillo M; Fillit H; Iwatsubo T; Jimenez-Maggiora G; Lovestone S; Natanegara F; Papp K; Soto ME; Weiner M; Vellas B
    J Prev Alzheimers Dis; 2021; 8(4):513-519. PubMed ID: 34585227
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Huntington's Disease Regulatory Science Consortium: Accelerating Medical Product Development.
    Turner EC; Gantman EC; Sampaio C; Sivakumaran S
    J Huntingtons Dis; 2022; 11(2):97-104. PubMed ID: 35466945
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Digital Health Technology for Real-World Clinical Outcome Measurement Using Patient-Generated Data: Systematic Scoping Review.
    Pyper E; McKeown S; Hartmann-Boyce J; Powell J
    J Med Internet Res; 2023 Oct; 25():e46992. PubMed ID: 37819698
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Artificial Intelligence Applications for Assessment, Monitoring, and Management of Parkinson Disease Symptoms: Protocol for a Systematic Review.
    Bounsall K; Milne-Ives M; Hall A; Carroll C; Meinert E
    JMIR Res Protoc; 2023 Jun; 12():e46581. PubMed ID: 37314853
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Measuring hot flashes: summary of a National Institutes of Health workshop.
    Miller HG; Li RM
    Mayo Clin Proc; 2004 Jun; 79(6):777-81. PubMed ID: 15182093
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Public-private partnerships as driving forces in the quest for innovative medicines.
    Goldman M; Compton C; Mittleman BB
    Clin Transl Med; 2013 Jan; 2(1):2. PubMed ID: 23369569
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Application of implementation science framework to develop and adopt regulatory science in different national regulatory authorities.
    Shi J; Chen X; Hu H; Ung COL
    Front Public Health; 2023; 11():1172557. PubMed ID: 37213606
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metadata Concepts for Advancing the Use of Digital Health Technologies in Clinical Research.
    Badawy R; Hameed F; Bataille L; Little MA; Claes K; Saria S; Cedarbaum JM; Stephenson D; Neville J; Maetzler W; Espay AJ; Bloem BR; Simuni T; Karlin DR
    Digit Biomark; 2019; 3(3):116-132. PubMed ID: 32175520
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Machine Learning and Digital Biomarkers Can Detect Early Stages of Neurodegenerative Diseases.
    Chudzik A; Śledzianowski A; Przybyszewski AW
    Sensors (Basel); 2024 Feb; 24(5):. PubMed ID: 38475108
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of summer programmes on the outcomes of disadvantaged or 'at risk' young people: A systematic review.
    Muir D; Orlando C; Newton B
    Campbell Syst Rev; 2024 Jun; 20(2):e1406. PubMed ID: 38873396
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Digital Tools-Regulatory Considerations for Application in Clinical Trials.
    Gelis L; Stoeckert I; Podhaisky HP
    Ther Innov Regul Sci; 2023 Jul; 57(4):769-782. PubMed ID: 37195515
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Qualitative evidence synthesis informing our understanding of people's perceptions and experiences of targeted digital communication.
    Ryan R; Hill S
    Cochrane Database Syst Rev; 2019 Oct; 10():ED000141. PubMed ID: 31643081
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.